This illustration shows how human breast cancer cells in a mouse model were “chased” with novel rare earth nanoscale probes injected intravenously. When the subject is illuminated, the probes glow in an infrared range of light that is more sensitive than other optical forms of illumination. In this case, the probes show the spread of cancer cells to adrenal glands and femur (thigh) bones.
Image: Harini Kantamneni and Professor Prabhas Moghe/Rutgers University-New Brunswick
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumors
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.
The technology could improve patient cure rates and survival times.
“We’ve always had this dream that we can track the progression of cancer in real time, and that’s what we’ve done here,” said Prabhas V. Moghe, a corresponding author of the study and distinguished professor of biomedical engineering and chemical and biochemical engineering at Rutgers-New Brunswick. “We’ve tracked the disease in its very incipient stages.”
The study, published online Dec.11 in Nature Biomedical Engineering, shows that the new method is better than magnetic resonance imaging (MRI) and other cancer surveillance technologies. The research team included Rutgers’ flagship research institution (Rutgers University-New Brunswick) and its academic health center (Rutgers Biomedical and Health Sciences, or RBHS).
“The Achilles’ heel of surgical management for cancer is the presence of micro metastases. This is also a problem for proper staging or treatment planning. The nanoprobes described in this paper will go a long way to solving these problems,” said Steven K. Libutti, director of Rutgers Cancer Institute of New Jersey. He is senior vice president of oncology services for RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences.
The ability to spot early tumors that are starting to spread remains a major challenge in cancer diagnosis and treatment, as most imaging methods fail to detect small cancerous lesions. But the Rutgers study shows that tiny tumors in mice can be detected with the injection of nanoprobes, which are microscopic optical devices, that emit short-wave infrared light as they travel through the bloodstream – even tracking tiny tumors in multiple organs.
The nanoprobes were significantly faster than MRIs at detecting the minute spread of tiny lesions and tumors in the adrenal glands and bones in mice. That would likely translate to detection months earlier in people, potentially resulting in saved lives, said Vidya Ganapathy, a corresponding author and assistant research professor in the Department of Biomedical Engineering.
“Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go,” she said. “You can treat the tumors intelligently because now you know the address of the cancer.”
The technology could be used to detect and track the 100-plus types of cancer, and could be available within five years, Moghe said. Real-time surveillance of lesions in multiple organs should lead to more accurate pre- and post-therapy monitoring of cancer.
“You can potentially determine the stage of the cancer and then figure out what’s the right approach for a particular patient,” he said.
In the future, nanoprobes could be used in any surgeries to mark tissues that surgeons want to remove, the researchers said. The probes could also be used to track the effectiveness of immunotherapy, which includes stimulating the immune system to fight cancer cells.
Learn more: Faster, More Accurate Cancer Detection Using Nanoparticles, Rutgers-Led Study Finds
The Latest on: Cancer detection and tracking
- Berry Oncology to launch multi-cancer early detection test within the yearon May 18, 2022 at 11:25 pm
Berry Oncology, a leading Chinese company in genetic testing and early screening of tumors, plans to launch an early cancer screening product within the year that is capable in detecting six prevalent ...
- Isabl's rapid whole-genome analysis opens the playbook for cancer treatmenton May 18, 2022 at 9:52 am
Every cancer is unique because every person is unique, and one of the most important weapons in any cancer battle is information. Isabl offers that in abundance through rapid sequencing of cancer ...
- Novel blood test can detect early-stage bowel canceron May 18, 2022 at 8:42 am
It takes one of the longest waiting times for diagnosis and treatments ... Doctors can then fast-track patients for early treatment. "It's like a cancer fingerprint," Ann Tate, CEO of Cancer ...
- Connections: Cancer-detection study seeks enrollees | Spring 2022on May 18, 2022 at 1:54 am
Not only will enrollees have the opportunity to gather key information about their own health, they will also help to advance opportunities for early cancer detection across a variety of oncological ...
- Treatment and Follow-up Care for Premenopausal Women With Breast Canceron May 17, 2022 at 7:08 am
Drs Lidia Schapira and Kathryn Ruddy discuss treatment and follow-up care for premenopausal women with breast cancer.
- Addy Wiley is Indiana's fastest teen miler — and a cancer survivoron May 17, 2022 at 2:04 am
On Huntington North's Addy Wiley: "She’s a real star and carries the banner well for childhood cancer survivors everywhere.” ...
- The Start to Rolling the Dice After my Cancer Diagnosison May 12, 2022 at 8:33 am
My breast cancer diagnosis changed all of that. This disease of mine forced me to make nebulous choices based on quickly collected facts, anecdotal stories and gut feelings. Almost overnight I became ...
- Fluorescent Probe Can Track Cancer Drug Progresson May 11, 2022 at 1:33 am
A new fluorescent probe could be used to track the activity of the immune system as it fights against cancer, enabling effective monitoring of cancer treatments.
- Fluorescent probe can track cancer drug progress, study showson May 10, 2022 at 9:06 am
Early diagnosis and treatment of cancer patients could be helped by new imaging technology that sheds light on the effectiveness of immunotherapy drugs.
- ‘Mya is the definition of a Warrior’: After cancer diagnosis derails her senior year, Wahoo’s Emerson makes triumphant return to the trackon May 7, 2022 at 7:00 pm
In a blur, volleyball matches and English classes turned into doctor visits and CT scans for Mya Emerson, who had her senior year turned upside down.
via Google News and Bing News
